Kura Oncology, Inc. (KURA)
NASDAQ
9.61
-0.25 (-2.54%)
Closed
Oct 23, 2026
Day's Range
9.289.84
52 wk Range
7.3613.90
Financial Statements - KURA - Kura Oncology, Inc.
Revenue
67.48M▲ 25.2%
Net Income
-278.66M▼ 60.2%Net Margin -412.9%
EBITDA
-275.82M▼ 62.7%
Free Cash Flow
-70.69M▼ 152.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 67.48M | 53.88M | 0 | 0 | 0 | 0 |
| Cost of Goods | 57K | - | - | - | - | - |
| Gross Profit | 67.42M | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -303.63M | -193.19M | -165.80M | -139.86M | -131.25M | -91.89M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | 51K |
| Pre Tax Income | -278.36M | -171.96M | -152.63M | -135.84M | -130.46M | -89.62M |
| Income Tax | 297K | 2.01M | - | - | - | - |
| Net Income | -278.66M | -173.98M | -152.63M | -135.84M | -130.46M | -89.62M |
| EPS Basic | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 | -1.69 |
| EPS Diluted | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 | -1.69 |
| Basic Shares Outstanding | 87.67M | 86.16M | 73.22M | 66.99M | 66.35M | 53.07M |
| Diluted Shares Outstanding | 87.67M | 86.16M | 73.22M | 66.99M | 66.35M | 53.07M |
| Ebit | -276.85M | -170.34M | -151.08M | -135.61M | -130.05M | -89.04M |
| Ebitda | -275.82M | -169.49M | -150.23M | -134.85M | -129.49M | -88.85M |
| Net Income Continuous Operations | -278.66M | -173.98M | -152.63M | -135.84M | -130.46M | -89.62M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
